MEU:PA:PA-Lyxor UCITS MSCI Europe D-EUR (EUR)

ETF | Others |

Last Closing

USD 199.65

Change

+0.97 (+0.49)%

Market Cap

USD 0.71B

Volume

2.75K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

N/A

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+3.50 (+0.60%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+1.55 (+0.37%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

+0.23 (+0.63%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.48 (+0.58%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+5.00 (+0.98%)

USD 8.92B
WLD:PA Lyxor UCITS MSCI World D-EUR

+2.01 (+0.55%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

+0.28 (+0.48%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.12 (+0.59%)

USD 6.91B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.91 (+0.55%)

USD 5.17B

ETFs Containing MEU:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.19% 87% B+ 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.19% 87% B+ 78% C+
Trailing 12 Months  
Capital Gain 15.08% 56% F 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.08% 54% F 67% D+
Trailing 5 Years  
Capital Gain 41.09% 58% F 70% C-
Dividend Return 1.56% 3% F 3% F
Total Return 42.65% 57% F 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 12.12% 66% D+ 68% D+
Dividend Return 12.36% 65% D 83% B
Total Return 0.25% 33% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 12.23% 56% F 86% B+
Risk Adjusted Return 101.11% 81% B- 94% A
Market Capitalization 0.71B 73% C 75% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.